Severe reverse amblyopia with atropine penalization.

Amblyopia Atropine Esotropia Humans Mydriatics Visual Acuity

Journal

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
ISSN: 1528-3933
Titre abrégé: J AAPOS
Pays: United States
ID NLM: 9710011

Informations de publication

Date de publication:
04 2020
Historique:
received: 03 11 2019
revised: 01 12 2019
accepted: 04 12 2019
pubmed: 19 1 2020
medline: 27 7 2021
entrez: 19 1 2020
Statut: ppublish

Résumé

We report 2 cases of refractory reverse amblyopia that developed after instillation of 1-4 drops of atropine. Risk factors appear to include age <4, large-angle esotropia, and lack of adherence to spectacle wear.

Identifiants

DOI: 10.1016/j.jaapos.2019.12.001 PMID: 31953022
pubmed: 31953022
pii: S1091-8531(20)30014-8
doi: 10.1016/j.jaapos.2019.12.001
pii:
doi:

Substances chimiques

Mydriatics 0
Atropine 7C0697DR9I

Types de publication

Case Reports Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106-108

Informations de copyright

Copyright © 2020 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.

Auteurs

Abdelrahman M Elhusseiny (AM)

Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

Carolyn Wu (C)

Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

Sarah MacKinnon (S)

Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

David G Hunter (DG)

Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: david.hunter@childrens.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Manifestations neurologiques › Troubles sensitifs › Troubles de la vision › Amblyopie › Severe reverse amblyopia with atropine penalization.
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques, cycle ponté › Tropanes › Atropines › Atropine › Severe reverse amblyopia with atropine penalization.
questionsmedicales.fr › Maladies de l'oeil › Troubles de la motilité oculaire › Strabisme › Ésotropie › Severe reverse amblyopia with atropine penalization.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Severe reverse amblyopia with atropine penalization.
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Agents du système nerveux périphérique › Agents du système nerveux autonome › Mydriatiques › Severe reverse amblyopia with atropine penalization.
questionsmedicales.fr › Phénomènes physiologiques oculaires › Acuité visuelle › Severe reverse amblyopia with atropine penalization.